ANNOUNCEMENT

Take a look at the MedCity ENGAGE program, with expert speakers from leading organizations. Reserve your place today.

Paul Quintaro,

Follow Paul Quintaro,: Website |

ZOLL Medical wins patent infringement case against ELan Med GmbH

ZOLL Medical wins patent infringement case against ELan Med GmbH

March 11, 2013 11:31 am by | 0 Comments

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the District Court of Munich, Germany, ruled in favor of ZOLL in granting an injunction ... Read more
Avanir Pharma to collaborate on research with VA Department for screening PBA symptoms

Avanir Pharma to collaborate on research with VA Department for screening PBA symptoms

March 6, 2013 9:03 am by | 0 Comments

Avanir Pharmaceuticals, Inc. in collaboration with the Department of Veterans Affairs (VA) and United BioSource Corporation (UBC) today announced a pilot study to screen for pseudobulbar affect (PBA) symptoms in ... Read more
Abiomed reimbursement update: Four commercial insurers start broad Impella coverage

Abiomed reimbursement update: Four commercial insurers start broad Impella coverage

March 4, 2013 8:16 am by | 0 Comments

Abiomed, Inc. (Nasdaq: ABMD), a leading provider of breakthrough heart support technologies, today provided a reimbursement update. Abiomed announced several recent Impella coverage decisions from national payers including Humana, UnitedHealthcare, ... Read more
FDA-approved obesity drug stalled in Europe

FDA-approved obesity drug stalled in Europe

February 21, 2013 5:01 pm by | 0 Comments

VIVUS, Inc. (Nasdaq: VVUS) announced today that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) confirmed its October 18, 2012 decision to decline the ... Read more

Merck resolves securities class-action suit related to ENHANCE, to record $493M charge

Merck resolves securities class-action suit related to ENHANCE, to record $493M charge

February 14, 2013 8:01 am by | 0 Comments

Merck (NYSE: MRK) known as MSD outside the United States and Canada, announced today that it has reached an agreement in principle with plaintiffs to resolve two federal securities ... Read more

Life Technologies’ genetic analyzers, HLA typing kits get FDA 510(k) ok for diagnostic use

Life Technologies’ genetic analyzers, HLA typing kits get FDA 510(k) ok for diagnostic use

February 11, 2013 8:03 am by | 0 Comments

Life Technologies Corporation (NASDAQ: LIFE) today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore® HLA typing kits. ... Read more

Kimberly-Clark boosts production of face mask products to address flu epidemic-related needs

Kimberly-Clark boosts production of face mask products to address flu epidemic-related needs

February 8, 2013 9:03 am by | 0 Comments

With the 2012-2013 influenza season reaching epidemic levels across the U.S., Kimberly-Clark (NYSE: KMB) is continuing to increase production of face masks and other Personal Protective Equipment (PPE) products ... Read more

St. Jude’s RESPECT trial for PFO closure highlighted at International Stroke Conference

St. Jude’s RESPECT trial for PFO closure highlighted at International Stroke Conference

February 8, 2013 8:10 am by | 0 Comments

St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today announced the presentation of additional data from its landmark RESPECT trial at the American Stroke Association's International ... Read more

Merck Serono, Opexa Therapeutics enter option, license agreement to develop Tcelna

Merck Serono, Opexa Therapeutics enter option, license agreement to develop Tcelna

February 5, 2013 7:41 am by | 0 Comments

Opexa Therapeutics, Inc. (NASDAQ: OPXA) today announced the execution of an agreement with Merck Serono, a division of Merck, Darmstadt, Germany, for the development and commercialization of Tcelna^™ (imilecleucel-T), ... Read more

Pfizer’s Zoetis IPO is the biggest since Facebook went public

Pfizer’s Zoetis IPO is the biggest since Facebook went public

February 1, 2013 9:58 am by | 0 Comments

Pfizer had a fantastic week with the successful initial public offering of its animal health unit. The IPO raised $2.2 billion and shares closed at $31.01 Friday. ... Read more
Medtronic completes enrollment in PAD study

Medtronic completes enrollment in PAD study

January 23, 2013 10:04 am by | 0 Comments

Medtronic, Inc. (NYSE: MDT), today announced completion of enrollment in IN.PACT SFA II, the U.S. arm of its clinical study for the IN.PACT Admiral drug-eluting balloon as a treatment ... Read more

Health Net walks from 6 Tenet hospitals in California over reimbursement

Health Net walks from 6 Tenet hospitals in California over reimbursement

December 27, 2012 11:32 am by | 0 Comments

Health Net, Inc. (NYSE: HNT) today announced that its subsidiaries exercised their contractual option to terminate agreements with all six of Tenet Healthcare's (NYSE: THC) Southern California hospitals.The terminations were ... Read more
Will new skin ulcer patent boost the fortunes of Oculus Innovative Sciences?

Will new skin ulcer patent boost the fortunes of Oculus Innovative Sciences?

December 27, 2012 9:13 am by | 0 Comments

Oculus Innovative Sciences, Inc. (Nasdaq: OCLS) a healthcare company that designs, produces and markets innovative, safe and effective anti-infective products and medical devices while also developing multiple drug candidates, today ... Read more
Kindred Healthcare to buy Homecare Advantage for $2M in cash

Kindred Healthcare to buy Homecare Advantage for $2M in cash

December 17, 2012 5:26 pm by | 0 Comments

Kindred Healthcare, Inc. (NYSE: KND) today announced that its subsidiary has acquired Homecare Advantage, Inc. for a purchase price of approximately $2 million in cash. Homecare Advantage is a high-quality ... Read more
Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

Janssen R&D submits NDA for canagliflozin/metformin fixed-dose combo therapy

December 12, 2012 2:05 pm by | 1 Comments

Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a fixed-dose therapy ... Read more